SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (11562)5/9/2018 9:27:51 PM
From: scaram(o)uche  Respond to of 12215
 
For some reason, I was expecting June rather than second half. So I'm not pleased, but guess I should be? Heh.

>> Partnering discussion... does not count in my book <<

Believe the Russian Olympic team has taken it into clinicals?

Is there progress to be made, other than partnering? Agree with you, investors are sort of hung out as targets, waiting for September's 24 week data. OTOH, that was almost cocky talk about partnering.



To: Miljenko Zuanic who wrote (11562)5/10/2018 1:05:24 PM
From: Miljenko Zuanic  Respond to of 12215
 
RE: VK2809

Based on planed bio-marker analysis for HeFH (MCP-1 & CK-18), regardless that P2 is not true NASH trial, it may (and probably will) point toward utility of this drug for NASH application.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News